Levin Capital Strategies’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
DCP
Levin Capital Strategies's AGL Position: Q3 2021 in Review
Levin Capital Strategies sold out of Agilon Health (AGL) in Q3 2021, closing a stake of 300 shares — an estimated $304K sold.
Levin Capital Strategies first reported a position in AGL in Q2 2021 and held it in 1 quarter. The position peaked at $304K in Q2 2021. 102 funds tracked by Wall St. Rank hold AGL as of Q3 2021.
- Levin Capital Strategies reported no remaining Agilon Health position as of Q3 2021 after selling out during the quarter.
- Levin Capital Strategies sold 300 Agilon Health shares in Q3 2021, an estimated $304K.
- Levin Capital Strategies first reported a position in Agilon Health in Q2 2021 and held it in 1 quarter.
- Levin Capital Strategies's Agilon Health position peaked at $304K in Q2 2021.
- 102 funds tracked by Wall St. Rank held Agilon Health as of Q3 2021.
Based on Levin Capital Strategies's 13F filing for Q3 2021, filed 10 Nov 2021.